Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP738418.RATy3uDllkq8h_sA1FuCdogLZAlgXhjFta41n5znzPFFQ130_assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738418.RATy3uDllkq8h_sA1FuCdogLZAlgXhjFta41n5znzPFFQ130_provenance.
• NP734021.RA9MxPM9zv4Z1rKrwxbOG3qYm5gLsAIji0fWDk8CsXwl4130_assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734021.RA9MxPM9zv4Z1rKrwxbOG3qYm5gLsAIji0fWDk8CsXwl4130_provenance.
• NP470483.RAOkokqUeQyCoqvjhbApPKEmAXX4JogXWL-7VDhRzD_iU130_assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470483.RAOkokqUeQyCoqvjhbApPKEmAXX4JogXWL-7VDhRzD_iU130_provenance.
• NP654898.RAJwuiJArj4Q_iqsg8Zfr9lyGNx10Bt3kNvZIFp7ItD0Q130_assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654898.RAJwuiJArj4Q_iqsg8Zfr9lyGNx10Bt3kNvZIFp7ItD0Q130_provenance.
• NP637047.RAQKSXyyl6tTCFTK4dUT51ReELse1VL7jdS9jP3fo3_V4130_assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637047.RAQKSXyyl6tTCFTK4dUT51ReELse1VL7jdS9jP3fo3_V4130_provenance.
• NP784192.RAziRUmG7JFyBfUnidaHaVyjSXQV9JysRhc29UbykgsoM130_assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784192.RAziRUmG7JFyBfUnidaHaVyjSXQV9JysRhc29UbykgsoM130_provenance.
• NP364199.RAWdFArx7kHDLejVB4TXWPfxtRUGJDhJzk8X267C6A-dQ130_assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364199.RAWdFArx7kHDLejVB4TXWPfxtRUGJDhJzk8X267C6A-dQ130_provenance.
• assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP364202.RAKJyxLEccTcOabDPDAFuwl1AemvhluurUrKUx0L0sW68130_assertion description "[PAX8-PPARgamma was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364202.RAKJyxLEccTcOabDPDAFuwl1AemvhluurUrKUx0L0sW68130_provenance.